Poland Coronary Stents Market Report 2022 to 2030

Poland Coronary Stents Market Analysis

$ 3999

Poland's Coronary Stents Market is expected to witness growth from $66 Mn in 2022 to $98 Mn in 2030 with a CAGR of 5.20% for the forecasted year 2022-30. The demand for minimally invasive procedures like stenting is increasing as individuals and healthcare professionals look for less invasive treatment choices more frequently. In Poland, the demand for coronary stents is being driven by this trend. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Balton, Metrum Cryoflex, Skamex, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare and Philips Healthcare.

ID: IN10PLMD006 CATEGORY: Medical Devices GEOGRAPHY: Poland AUTHOR: Jigyasu Bhandari

Buy Now

Poland Coronary Stents Healthcare Market Executive Analysis

Poland's Coronary Stents Market is expected to witness growth from $66 Mn in 2022 to $98 Mn in 2030 with a CAGR of 5.20% for the forecasted year 2022-30. Poland's 2020 health spending per person is $1347.23, or 6.3% of GDP, compared to the EU average of $3000, or 10.12% of GDP. Public funding only covers 72% of costs, which is less than the EU average of 79%. The somewhat high out-of-pocket expense (22%) raises accessibility problems. Despite a drop from 23% in 2014 to 19% in 2023, Poland still has a greater prevalence of daily smokers among adults than the majority of other European Union (EU) nations.

Around 2.5 million people in Poland have coronary artery disease. This is equivalent to about 6.5% of the Polish populace. The condition known as CAD, which happens when the coronary arteries constrict or block as a result of a build-up of plaque, is frequently treated with coronary stents. When drugs and lifestyle modifications fail to control CAD, stenting is frequently utilized as a treatment. Coronary stents assist in enhancing blood flow to the heart by maintaining the coronary arteries open, which can lower the risk of heart attack and other cardiovascular events. The condition known as restenosis is when the artery narrows once again subsequent stenting. Modern stents are made to lower the chance of restenosis, which might enhance patient outcomes and lessen the demand for additional surgeries.

Poland Coronary Stents Market Analysis

Market Dynamics

Market Growth Drivers

The demand for minimally invasive procedures like stenting is increasing as individuals and healthcare professionals look for less invasive treatment choices more frequently. In Poland, the demand for coronary stents is being driven by this trend. The market for these devices in Poland is being driven by the creation of novel stent designs such as drug-eluting stents and bioresorbable stents. These stents are more effective than conventional stent designs and are growing in acceptance among patients and healthcare professionals. In Poland, coronary artery disease and other cardiovascular diseases are on the rise. The market for medical devices like coronary stents is being driven by the rising prevalence of these illnesses.

Market Restraints

In Poland, healthcare professionals and patients must both consider the cost of cardiac stents. Manufacturers may experience pricing challenges that restrict their profitability due to increased competition and pressure to lower healthcare costs. Although Poland generally has good access to healthcare, there might be barriers or disparities in access to specific procedures or technologies, which could have an impact on the market for coronary stents. Although coronary stents are a common treatment for coronary artery disease, they are up against alternatives like medication therapy and coronary artery bypass surgery.

Competitive Landscape

Key Players

Balton (PL)
Metrum Cryoflex (PL)
Skamex (PL)
Biotronik
Boston Scientific
B. Braun
Abbott Laboratories
GE Healthcare
Medtronic
Philipps Healthcare

Healthcare Policies and Regulatory Landscape

In Poland, the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products (URPL) is in charge of the regulatory environment for coronary stents. Manufacturers of coronary stents in Poland are required to obtain a CE mark, which certifies that the product complies with the MDD or MDR, respectively, of the European Union's directive on medical devices. The National Health Fund (NFZ) sets the policies for medical device reimbursement, including those for coronary stents. Manufacturers are responsible for making sure their products are listed on the NFZ's reimbursement list and that they satisfy the standards for reimbursement.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Coronary Stents Market Segmentation

By Type (Revenue, USD Billion):

The three main categories of coronary stents are bare-metal, drug-eluting, and bioabsorbable, depending on their nature. The segment for bioabsorbable stents is anticipated to increase at the fastest rate over the forecast period. The benefits that are encouraging the use of bioabsorbable stents include a decrease in problems including thrombosis and inflammation, the cPolandity to restore normal vasomotion, and an improvement in aberrant endothelial function. However, in the upcoming years, the expansion of this market segment is anticipated to be constrained by the high cost of bioabsorbable stents.

Bare-metal Stents
Drug-eluting Stents
Bioabsorbable Stents

By Mode of Delivery (Revenue, USD Billion):

The market is divided into self-expanding and balloon-expandable stents according to delivery method. Because of the high use of these stents, rising research initiatives to advance the technology, and rising regulatory approvals for balloon-expandable stents, the balloon expandable stents segment is anticipated to increase at the greatest CAGR over the projection period.

Balloon-expandable Stents
Self-expanding Stents

By Materials (Revenue, USD Billion):

The coronary stent market is divided into metallic (cobalt chromium, platinum chromium, nickel-titanium, and stainless steel) and other stents according to the material. The market for other stents is anticipated to experience the largest CAGR growth during the projection period. The rapid expansion of this market can be ascribed to the increased use of polymers and copolymers in the production of bioabsorbable stents.

Metallic Stents
Cobalt-Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Other Stents

By End User (Revenue, USD Billion):

The coronary stent market is divided into hospitals, cardiac centres, and ambulatory surgical centres based on the end user. According to predictions, the hospital sector will control the market in 2016. This is primarily caused by hospitals using a lot of coronary stents.

Hospitals
Cardiac Centers
Ambulatory Surgical Centers

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.